AOL1mon
Novo Nordisk's $600 Million Gambit Could Be a Game Changer for the Stock. Here's Why.
Novo Nordisk (NYSE: NVO) just made a partnership play worth $600 million with a small biotech called NanoVation that might just change the stock's trajectory for many years to come. On Sept.
BioWorld1mon
Nanovation Therapeutics partners with Novo Nordisk on genetic medicines for cardiometabolic and rare diseases
Nanovation Therapeutics Inc. has established a multiyear partnership with Novo Nordisk A/S to advance the development of novel genetic medicines targeting cardiometabolic and rare diseases. The ...
PopVax Announces 1.15 Million USD in Funding from the Bill and Melinda Gates Foundation for Thermostable mRNA Delivery Formulation Development
BusinessWire India Mumbai Maharashtra Hyderabad Telangana [India] October 30 PopVax an Indian full-stack biotechnology ...
The Globe and Mail1mon
ME Therapeutics Announces the Start of Testing of First mRNA Formulations from NanoVation Therapeutics Collaboration
NanoVation Therapeutics' next-generation lipid nanoparticle platforms enable the efficient nucleic acid delivery to a variety of tissues. To efficiently target immune cells, NanoVation ...
PipelineReview.com10d
PopVax Announces 1.15 Million USD in Funding from the Bill & Melinda Gates Foundation for Thermostable mRNA Delivery Formulation Development
MUMBAI, India & HYDERABAD, India I October 30, 2024 I PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics ...